Paper39640574
CBP/p300 lysine acetyltransferases inhibit HIV-1 expression in latently infected T cells.
Horvath RM and 1 other. iScience, 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. CBP/p300 lysine acetyltransferases inhibit HIV-1 expression in latently infected T cells. Papers, record 39640574. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39640574
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CBP/p300 lysine acetyltransferases inhibit HIV-1 expression in latently infected T cells.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References75
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22355797 | Transcriptional and posttranscriptional regulation of HIV-1 gene expression. | Cold Spring Harb Perspect Med | 2012 | https://conductscience.org/library/papers/22355797 | PubMed |
| 2 | 35042977 | Modulation of cellular processes by histone and non-histone protein acetylation. | Nat Rev Mol Cell Biol | 2022 | https://conductscience.org/library/papers/35042977 | PubMed |
| 3 | 32220311 | Curing HIV: Seeking to Target and Clear Persistent Infection. | Cell | 2020 | https://conductscience.org/library/papers/32220311 | PubMed |
| 4 | 38547337 | The sounds of silencing: dynamic epigenetic control of HIV latency. | Curr Opin HIV AIDS | 2024 | https://conductscience.org/library/papers/38547337 | PubMed |
| 5 | 11285236 | The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. | EMBO J | 2001 | https://conductscience.org/library/papers/11285236 | PubMed |
| 6 | 9671771 | Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9671771 | PubMed |
| 7 | 21849433 | Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection. | J Virol | 2011 | https://conductscience.org/library/papers/21849433 | PubMed |
| 8 | 33400925 | Targeted degradation of the enhancer lysine acetyltransferases CBP and p300. | Cell Chem Biol | 2021 | https://conductscience.org/library/papers/33400925 | PubMed |
| 9 | 23041316 | Reactivation of latent HIV-1 by inhibition of BRD4. | Cell Rep | 2012 | https://conductscience.org/library/papers/23041316 | PubMed |
| 10 | 22020221 | The Suv39H1 methyltransferase inhibitor chaetocin causes induction of integrated HIV-1 without producing a T cell response. | FEBS Lett | 2011 | https://conductscience.org/library/papers/22020221 | PubMed |
| 11 | 21518915 | Dynamic acetylation of all lysine-4 trimethylated histone H3 is evolutionarily conserved and mediated by p300/CBP. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21518915 | PubMed |
| 12 | 19136668 | Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19136668 | PubMed |
| 13 | 30723126 | Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat. | mBio | 2019 | https://conductscience.org/library/papers/30723126 | PubMed |
| 14 | 22817991 | An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription. | Cell Host Microbe | 2012 | https://conductscience.org/library/papers/22817991 | PubMed |
| 15 | 38134881 | A histone deacetylase network regulates epigenetic reprogramming and viral silencing in HIV-infected cells. | Cell Chem Biol | 2023 | https://conductscience.org/library/papers/38134881 | PubMed |
| 16 | 26152583 | The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency. | mBio | 2015 | https://conductscience.org/library/papers/26152583 | PubMed |
| 17 | 37671866 | CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells. | J Virol | 2023 | https://conductscience.org/library/papers/37671866 | PubMed |
| 18 | 21715480 | Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2. | J Virol | 2011 | https://conductscience.org/library/papers/21715480 | PubMed |
| 19 | 31535023 | A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression, and cell death. | Sci Adv | 2019 | https://conductscience.org/library/papers/31535023 | PubMed |
| 20 | 29714165 | Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells. | Elife | 2018 | https://conductscience.org/library/papers/29714165 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42845533 | RelB proximity proteomics and CRISPR screening define chromatin regulators of noncanonical NF-κB control of HIV latency and reactivation. | bioRxiv | 2026 | https://conductscience.org/library/papers/42845533 | PubMed |
| 42824836 | Epigenetic regulation of HIV-1 transcription: insights into latency mechanisms and therapeutic strategies. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42824836 | PubMed |
| 42421472 | Hijacking the Host: Post-Translational Modifications as Molecular Switches in HIV Persistence and Immune Evasion. | J Med Virol | 2026 | https://conductscience.org/library/papers/42421472 | PubMed |
| 41160734 | Inhibition of Histone Deacetylases Induces Cancer Cell Apoptosis Through the PERK Pathway of ER Stress Response. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/41160734 | PubMed |
| 40726975 | Promotion of HIV clearance by sensitization of HIV reservoirs to cell death. | Front Immunol | 2025 | https://conductscience.org/library/papers/40726975 | PubMed |
| 40374607 | PRMT3 reverses HIV-1 latency by increasing chromatin accessibility to form a TEAD4-P-TEFb-containing transcriptional hub. | Nat Commun | 2025 | https://conductscience.org/library/papers/40374607 | PubMed |
| 40361117 | RYBP promotes HIV-1 latency through promoting H2AK119ub and decreasing H3K4me3. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40361117 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRD4 | 23476 | PubTator's text mining | https://conductscience.org/library/genes/23476 | NCBI Gene |
| KAT2A | 2648 | PubTator's text mining | https://conductscience.org/library/genes/2648 | NCBI Gene |
| KAT2B | 8850 | PubTator's text mining | https://conductscience.org/library/genes/8850 | NCBI Gene |
| KAT6A | 7994 | PubTator's text mining | https://conductscience.org/library/genes/7994 | NCBI Gene |
| KAT6B | 23522 | PubTator's text mining | https://conductscience.org/library/genes/23522 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39640574
GET https://conductscience.org/api/papers/v1/39640574/references?page=2